IDXX IDEXX Laboratories, Inc.
$519.26
IDEXX Laboratories, Inc. (IDXX) is expected to report earnings on November 2, 2026, before the market open. The consensus earnings estimate is $3.70 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.8% since its last earnings release on August 4, 2026.
IDEXX Laboratories Beat Consensus Estimates, Raises Earnings Guidance
Tuesday, August 4, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 2
Monday · 6:30 AM ET
Earnings Whisper
-
vs $3.70
Rev est $1.19B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$547.72
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About IDEXX Laboratories, Inc.
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for the veterinary, bioresearch, water, livestock, poultry and dairy markets.
Sector
Healthcare
Industry
Diagnostic Substances
Held By 12 ETFs, by dollar flow
- QQQ Invesco QQQ Trust
- QQQ Invesco QQQ Trust
- QNXT iShares Nasdaq-100 ex Top 30 ETF
- QNXT iShares Nasdaq-100 ex Top 30 ETF
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- IHI iShares U.S. Medical Devices ETF
- IHI iShares U.S. Medical Devices ETF
Charts powered in part by Lightweight Charts™ by TradingView.